New @BioMedCentral Paper by @UICPhysiology While estrogen receptor (ER) positive breast tumors generally respond well to endocrine therapy (ET), up to 40% of patients will experience relapse, either while on endocrine therapy or after ET is completed. h
383 followers
2,217 followers
RT @UICPhysiology: Congratulations to Dr. Frasor and her team for their latest publication in @BCRJournal! https://t.co/GGK6MsUGfC @uiccom…
3,625 followers
RT @UICPhysiology: Congratulations to Dr. Frasor and her team for their latest publication in @BCRJournal! https://t.co/GGK6MsUGfC @uiccom…
477 followers
Congratulations to Dr. Frasor and her team for their latest publication in @BCRJournal! https://t.co/GGK6MsUGfC @uiccom @UICancerCenter